A Prospective Study of Fractional Flow Reserve Assessment of Intermediate Coronary Stenoses in Severe Aortic Stenosis



Status:Recruiting
Conditions:Cardiology, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:20 - 110
Updated:3/6/2019
Start Date:February 14, 2018
End Date:December 31, 2019
Contact:Jayendrakumar S Patel, MD
Email:patelj2@ccf.org
Phone:2169734728

Use our guide to learn which trials are right for you!

Coronary artery blockages can reduce blood flow to the heart muscle. Fractional flow reserve
(iFR or FFR) assessment is an invasive tool used to determine how much blood flow is reduced.
The investigators will perform iFR/FFR on all intermediate coronary stenoses using standard
practice, immediately before (at the time of) transcatheter aortic valve replacement (TAVR)
and after successful TAVR. The investigators will compare pre- and post-TAVR iFR/FFR values,
and assess short-term outcomes. The investigators hypothesize that iFR/FFR values will be
consistently and significantly higher pre-TAVR in comparison with post-TAVR for the same
lesions.

The purpose of the study is to determine whether iFR assessment gives a valid assessment of
coronary hemodynamics in patients with severe aortic stenosis.

Several factors confound the interpretation of fractional flow reserve (FFR) in patients with
severe aortic stenosis (AS) and intermediate severity coronary stenoses, and the widely
accepted cut-off value of 0.80 may not be applicable to this patient population. Coronary
flow reserve is known to be attenuated under conditions of left ventricular hypertrophy and
severe AS, with one study showing improvement in coronary flow reserve after aortic valve
replacement. Left ventricular hypertrophy produces fixed resistance secondary to external
compression of the coronary microcirculation. This potentially results in failure to achieve
maximal hyperemia with adenosine and can lead to false negative FFR results. Neurohormonal
influences in aortic stenosis can further attenuate vasodilator response and potentially
result in false negative FFR values. Both of these conditions result in the potential
deferral of lesions which may have been hemodynamically significant in the absence of severe
AS. At present, there are no studies which have demonstrated validity of FFR measurement in
patients with severe AS. Here, the investigators propose a prospective study of iFR/FFR in
patients with AS and indeterminate coronary lesions undergoing TAVR to understand the
hemodynamic consequences of AS on iFR/FFR. The investigators hypothesize that iFR/FFR values
will be consistently and significantly higher pre-TAVR in comparison with post-TAVR for the
same lesions.

Inclusion Criteria:

- All patients who have coronary stenoses between 40-70% severity and who have severe
aortic stenosis undergoing TAVR work-up.

Exclusion Criteria:

- Patients with documented intraprocedural hemodynamic instability, shock, or major
adverse event (myocardial infarction, aortic rupture/dissection, stroke, left
ventricular perforation, cardiac arrest).

- Contraindication to adenosine, presence of cardiogenic shock, presence of acute
coronary syndrome.
We found this trial at
1
site
9500 Euclid Avenue
Cleveland, Ohio 44106
216.444.2200
Phone: 216-973-4728
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials